Cargando…

Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation

BACKGROUND: People who inject drugs (PWID) are at risk for HIV and opioid overdose. We piloted PARTNER UP, a telemedicine-based program to provide PWID with access to both oral pre-exposure prophylaxis (PrEP) for HIV prevention and medication for opioid use disorder (MOUD) through two syringe servic...

Descripción completa

Detalles Bibliográficos
Autores principales: Corneli, Amy, Perry, Brian, Des Marais, Andrea, Choi, Yujung, Chen, Hillary, Lilly, Rebecca, Ayers, Denae, Bennett, Jesse, Kestner, Lauren, Meade, Christina S., Sachdeva, Nidhi, McKellar, Mehri S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719634/
https://www.ncbi.nlm.nih.gov/pubmed/36463214
http://dx.doi.org/10.1186/s12954-022-00718-1
_version_ 1784843366621511680
author Corneli, Amy
Perry, Brian
Des Marais, Andrea
Choi, Yujung
Chen, Hillary
Lilly, Rebecca
Ayers, Denae
Bennett, Jesse
Kestner, Lauren
Meade, Christina S.
Sachdeva, Nidhi
McKellar, Mehri S.
author_facet Corneli, Amy
Perry, Brian
Des Marais, Andrea
Choi, Yujung
Chen, Hillary
Lilly, Rebecca
Ayers, Denae
Bennett, Jesse
Kestner, Lauren
Meade, Christina S.
Sachdeva, Nidhi
McKellar, Mehri S.
author_sort Corneli, Amy
collection PubMed
description BACKGROUND: People who inject drugs (PWID) are at risk for HIV and opioid overdose. We piloted PARTNER UP, a telemedicine-based program to provide PWID with access to both oral pre-exposure prophylaxis (PrEP) for HIV prevention and medication for opioid use disorder (MOUD) through two syringe services programs (SSPs) in North Carolina. We conducted a qualitative evaluation to assess the acceptability and feasibility of PARTNER UP from the participant perspective. METHODS: PARTNER UP participants met with a provider for an initial in-person visit at the SSP, followed by weekly telemedicine visits in month 1 and then monthly telemedicine visits until program end at month 6. Using a qualitative descriptive study design, we conducted in-depth interviews with a subsample of PARTNER UP participants at 1 month and 4 months. Informed by the technology acceptance model, we assessed participant perceptions of the usefulness and ease of use of PARTNER UP, as well as their intent to continue to use the program’s components. We audio-recorded all interviews with participants’ permission and used applied thematic analysis to analyze the verbatim transcripts. RESULTS: We interviewed 11 of 17 people who participated in PARTNER UP—10 in the month 1 interview and 8 in the month 4 interview. Nearly all participants were motivated to join for consistent and easy access to buprenorphine/naloxone (i.e., MOUD); only a few joined to access PrEP. Most were comfortable accessing healthcare at the SSP because of their relationship with and trust toward SSP staff, and accessing services at the SSP was preferred compared with other healthcare centers. Some participants described that telemedicine allowed them to be honest and share more information because the visits were not in-person and they chose the location, although the initial in-person meeting was helpful to build provider trust and rapport. Most participants found the visit schedule to be feasible, although half described needing to reschedule at least once. Nearly all participants who were interviewed intended to continue with MOUD after the program ended, whereas none were interested in continuing with PrEP. CONCLUSIONS: Participant narratives suggest that the PARTNER UP telemedicine program was acceptable and feasible. Future studies should continue to explore the benefits of embedding both PrEP and MOUD into SSPs with larger numbers of participants. Trial registration Clinicaltrials.gov Identifier: NCT04521920.
format Online
Article
Text
id pubmed-9719634
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-97196342022-12-05 Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation Corneli, Amy Perry, Brian Des Marais, Andrea Choi, Yujung Chen, Hillary Lilly, Rebecca Ayers, Denae Bennett, Jesse Kestner, Lauren Meade, Christina S. Sachdeva, Nidhi McKellar, Mehri S. Harm Reduct J Research BACKGROUND: People who inject drugs (PWID) are at risk for HIV and opioid overdose. We piloted PARTNER UP, a telemedicine-based program to provide PWID with access to both oral pre-exposure prophylaxis (PrEP) for HIV prevention and medication for opioid use disorder (MOUD) through two syringe services programs (SSPs) in North Carolina. We conducted a qualitative evaluation to assess the acceptability and feasibility of PARTNER UP from the participant perspective. METHODS: PARTNER UP participants met with a provider for an initial in-person visit at the SSP, followed by weekly telemedicine visits in month 1 and then monthly telemedicine visits until program end at month 6. Using a qualitative descriptive study design, we conducted in-depth interviews with a subsample of PARTNER UP participants at 1 month and 4 months. Informed by the technology acceptance model, we assessed participant perceptions of the usefulness and ease of use of PARTNER UP, as well as their intent to continue to use the program’s components. We audio-recorded all interviews with participants’ permission and used applied thematic analysis to analyze the verbatim transcripts. RESULTS: We interviewed 11 of 17 people who participated in PARTNER UP—10 in the month 1 interview and 8 in the month 4 interview. Nearly all participants were motivated to join for consistent and easy access to buprenorphine/naloxone (i.e., MOUD); only a few joined to access PrEP. Most were comfortable accessing healthcare at the SSP because of their relationship with and trust toward SSP staff, and accessing services at the SSP was preferred compared with other healthcare centers. Some participants described that telemedicine allowed them to be honest and share more information because the visits were not in-person and they chose the location, although the initial in-person meeting was helpful to build provider trust and rapport. Most participants found the visit schedule to be feasible, although half described needing to reschedule at least once. Nearly all participants who were interviewed intended to continue with MOUD after the program ended, whereas none were interested in continuing with PrEP. CONCLUSIONS: Participant narratives suggest that the PARTNER UP telemedicine program was acceptable and feasible. Future studies should continue to explore the benefits of embedding both PrEP and MOUD into SSPs with larger numbers of participants. Trial registration Clinicaltrials.gov Identifier: NCT04521920. BioMed Central 2022-12-03 /pmc/articles/PMC9719634/ /pubmed/36463214 http://dx.doi.org/10.1186/s12954-022-00718-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Corneli, Amy
Perry, Brian
Des Marais, Andrea
Choi, Yujung
Chen, Hillary
Lilly, Rebecca
Ayers, Denae
Bennett, Jesse
Kestner, Lauren
Meade, Christina S.
Sachdeva, Nidhi
McKellar, Mehri S.
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
title Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
title_full Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
title_fullStr Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
title_full_unstemmed Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
title_short Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
title_sort participant perceptions on the acceptability and feasibility of a telemedicine-based hiv prep and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9719634/
https://www.ncbi.nlm.nih.gov/pubmed/36463214
http://dx.doi.org/10.1186/s12954-022-00718-1
work_keys_str_mv AT corneliamy participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT perrybrian participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT desmaraisandrea participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT choiyujung participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT chenhillary participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT lillyrebecca participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT ayersdenae participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT bennettjesse participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT kestnerlauren participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT meadechristinas participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT sachdevanidhi participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation
AT mckellarmehris participantperceptionsontheacceptabilityandfeasibilityofatelemedicinebasedhivprepandbuprenorphinenaloxoneprogramembeddedwithinsyringeservicesprogramsaqualitativedescriptiveevaluation